2 recruiting. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 2 |
| Phase 2 | 1 | Recruiting 1 |
Follow Neuroendocrine Carcinomas: new trials by email Literature Review of Neuroendocrine Carcinomas trials Research Report on Neuroendocrine Carcinomas
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer IDE849, durvalumab, IDE161 - Small-cell Lung Cancer, Neuroendocrine Carcinomas | Phase 1 / Phase 2 | Recruiting | IDEAYA Biosciences | 262 | 2025-10-14 | 2026-07-09 |
| A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors ADCT-701 - Neuroendocrine Carcinomas, Neuroendocrine Tumors | Phase 1 | Recruiting | National Cancer Institute (NCI) | 70 | 2024-06-17 | 2026-11-02 |
Carcinoma, Neuroendocrine (2) · Adrenocortical Carcinoma (1) · Neuroblastoma (1) · Neuroendocrine Tumors (1) · Paraganglioma (1) · Pheochromocytoma (1) · Small Cell Lung Carcinoma (1)
Adenocarcinoma (2) · Carcinoma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms by Site (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Neoplasms, Nerve Tissue (2) · Neuroectodermal Tumors (2) · Adrenal Cortex Diseases (1) · Adrenal Cortex Neoplasms (1) · Adrenal Gland Diseases (1) · Adrenal Gland Neoplasms (1) · Bronchial Neoplasms (1) · Carcinoma, Bronchogenic (1)
Carboplatin (1) · durvalumab (1)
IDEAYA Biosciences (1) · National Cancer Institute (NCI) (1)
United States (2)